Advertisement
Advertisement

OCGN

OCGN logo

Ocugen, Inc. Common Stock

1.55
USD
+0.07
+5.07%
Oct 31, 15:44 UTC -4
Closed
exchange

After-Market

1.56

+0.01
+0.32%

Ocugen, Inc. Common Stock Profile

About

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.

Info & Links

CEO

Shankar Musunuri

Headquarters

11 GREAT VALLEY PARKWAY
MALVERN, PA 19355, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

http://ocugen.com

Auditor

PricewaterhouseCoopers LLP

Share holders

26

Employees

95

Ocugen, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

487.20M

Enterprise Value

488.21M

Enterprise Value/EBITDA(ttm)

-9.33

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

95.92

Price to Book(mrq)

149.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-1197.71%

Profit Margin(ttm)

-1267.11%

Return on Equity(ttm)

-255.25%

Return on Invested Capital(ttm)

-137.74%

Return on Assets(ttm)

-86.79%

Income Statement

Revenue(ttm)

4.75M

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

4.75M

EBITDA(ttm)3

-52.34M

Net Income Available to Common(ttm)

-56.94M

Diluted EPS(ttm)

-0.20

Share Statistics

Beta (5Y Monthly)

4.20

52-Week Change

59.65%

S&P 500 52-Week Change

19.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

292.30M

Dividend Yield

0.00%

Float4

279.38M

% Held by Insiders

4.42%

% Held by Institutions

10.27%

Balance Sheet

Total Cash(mrq)

27.01M

Total Cash Per Share(mrq)

0.09

Total Debt(mrq)

28.02M

Total Debt/Equity(mrq)

918.25%

Current Ratio(mrq)

1.83%

Quick Ratio(mrq)

1.83%

Book Value Per Share(mrq)

0.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.10

Free Cash Flow(ytd)

-30.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement